Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Nat Rev Cardiol. 2019 Mar;16(3):137–154. doi: 10.1038/s41569-018-0108-7

Figure 4. The relationship between plasma levels of TMAO and 5yr mortality risk in Patients with Chronic Heart Failure.

Figure 4.

Legend: Patients with a history of heart failure stratified according to quartiles of fasting TMAO levels and circulating B-type natriuretic peptide (BNP) levels showing an increased incidence of 5-year mortality with rising TMAO levels, independent of BNP levels (from Tang WH et al., J Am Coll Cardiol 2014)181